ATE401878T1 - Verwendung von phenoxyessigsäurederivaten zur behandlung der hyperaktiven blase - Google Patents

Verwendung von phenoxyessigsäurederivaten zur behandlung der hyperaktiven blase

Info

Publication number
ATE401878T1
ATE401878T1 AT04722967T AT04722967T ATE401878T1 AT E401878 T1 ATE401878 T1 AT E401878T1 AT 04722967 T AT04722967 T AT 04722967T AT 04722967 T AT04722967 T AT 04722967T AT E401878 T1 ATE401878 T1 AT E401878T1
Authority
AT
Austria
Prior art keywords
acid derivatives
phenoxyacetic acid
hyperactive bladder
treat
treat hyperactive
Prior art date
Application number
AT04722967T
Other languages
German (de)
English (en)
Inventor
Yoshinobu Yamazaki
Masami Kojima
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33420009&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE401878(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE10320084A external-priority patent/DE10320084A1/de
Priority claimed from DE2003123837 external-priority patent/DE10323837A1/de
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Application granted granted Critical
Publication of ATE401878T1 publication Critical patent/ATE401878T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT04722967T 2003-05-05 2004-03-24 Verwendung von phenoxyessigsäurederivaten zur behandlung der hyperaktiven blase ATE401878T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10320084A DE10320084A1 (de) 2003-05-05 2003-05-05 Verwendung von Phenoxyessigsäurederivaten zur Behandlung der hyperaktiven Blase
DE2003123837 DE10323837A1 (de) 2003-05-23 2003-05-23 Verwendung von Phenoxyessigsäurederivaten zur Behandlung der hyperaktiven Blase

Publications (1)

Publication Number Publication Date
ATE401878T1 true ATE401878T1 (de) 2008-08-15

Family

ID=33420009

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04722967T ATE401878T1 (de) 2003-05-05 2004-03-24 Verwendung von phenoxyessigsäurederivaten zur behandlung der hyperaktiven blase

Country Status (26)

Country Link
US (1) US20040229947A1 (https=)
EP (1) EP1620085B1 (https=)
JP (1) JP4602969B2 (https=)
KR (1) KR101052804B1 (https=)
AR (1) AR044169A1 (https=)
AT (1) ATE401878T1 (https=)
AU (1) AU2004236596B2 (https=)
BR (1) BRPI0409980A (https=)
CA (1) CA2524023C (https=)
CL (1) CL2004000952A1 (https=)
CY (1) CY1108425T1 (https=)
DE (1) DE602004015272D1 (https=)
DK (1) DK1620085T3 (https=)
ES (1) ES2309513T3 (https=)
IL (1) IL171713A (https=)
MX (1) MXPA05011862A (https=)
MY (1) MY141756A (https=)
NZ (1) NZ543347A (https=)
PE (1) PE20050524A1 (https=)
PL (1) PL1620085T3 (https=)
PT (1) PT1620085E (https=)
RU (1) RU2342133C2 (https=)
SI (1) SI1620085T1 (https=)
TW (1) TWI351279B (https=)
UY (1) UY28306A1 (https=)
WO (1) WO2004098586A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI356699B (en) * 2004-11-10 2012-01-21 Kissei Pharmaceutical Agent for treating interstitial cystitis and agent
WO2006118087A1 (ja) * 2005-04-26 2006-11-09 Kissei Pharmaceutical Co., Ltd. ヒドロキシノルエフェドリン誘導体塩酸塩・１／４水和物の結晶
EP1878719A4 (en) * 2005-04-26 2010-10-06 Kissei Pharmaceutical HYDROXYNOREPHEDRINE DERIVATIVE HYDROCHLORIDE POLYMORPH CRYSTAL
EP1769792A1 (de) * 2005-09-30 2007-04-04 Boehringer Ingelheim Pharma GmbH & Co.KG Verwendung eines beta-3-Adrenozeptor-Agonisten zur Behandlung von Nieren- und Blasenbeschwerden
EP3634420A1 (en) 2017-06-06 2020-04-15 Urovant Sciences GmbH Use of vibegron to treat overactive bladder

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254469B (it) * 1992-02-25 1995-09-25 Recordati Chem Pharm Derivati benzopiranici e benzotiopiranici
US6262115B1 (en) * 1995-05-22 2001-07-17 Alza Coporation Method for the management of incontinence
US6720014B1 (en) * 1997-08-13 2004-04-13 Diversa Corporation Phytase-containing foodstuffs and methods of making and using them
MY126489A (en) * 1998-07-08 2006-10-31 Kissei Pharmaceutical Phenoxyacetic acid derivatives and medicinal compositions containing the same
DE60041110D1 (de) * 1999-11-01 2009-01-29 Sumitomo Chemical Co 6-Hydroxy-5,6-dihydrouracile als Herbizide
UA77000C2 (en) * 2001-09-13 2006-10-16 Kissei Pharmaceutical Crystalline form of hydroxynorephedrine derivative

Also Published As

Publication number Publication date
IL171713A (en) 2011-12-29
TWI351279B (en) 2011-11-01
CA2524023C (en) 2011-11-22
BRPI0409980A (pt) 2006-05-09
KR20060009886A (ko) 2006-02-01
RU2005137701A (ru) 2006-06-10
NZ543347A (en) 2008-05-30
EP1620085B1 (en) 2008-07-23
RU2342133C2 (ru) 2008-12-27
MY141756A (en) 2010-06-30
WO2004098586A1 (en) 2004-11-18
EP1620085A1 (en) 2006-02-01
UY28306A1 (es) 2004-12-31
AU2004236596A1 (en) 2004-11-18
PE20050524A1 (es) 2005-07-07
MXPA05011862A (es) 2006-02-17
AR044169A1 (es) 2005-08-24
US20040229947A1 (en) 2004-11-18
JP2006525318A (ja) 2006-11-09
KR101052804B1 (ko) 2011-07-29
DK1620085T3 (da) 2008-11-24
PT1620085E (pt) 2008-08-07
JP4602969B2 (ja) 2010-12-22
CA2524023A1 (en) 2004-11-18
SI1620085T1 (sl) 2008-12-31
ES2309513T3 (es) 2008-12-16
CY1108425T1 (el) 2014-04-09
PL1620085T3 (pl) 2009-01-30
CL2004000952A1 (es) 2005-03-04
TW200509902A (en) 2005-03-16
AU2004236596B2 (en) 2010-03-11
DE602004015272D1 (de) 2008-09-04

Similar Documents

Publication Publication Date Title
ATE452642T1 (de) Verwendung von cox-2 inhibitoren zur behandlung von affectiven störungen
ATE419856T1 (de) Verwendung von rimexolon zur behandlung von augentrockenheit
ATE429225T1 (de) 5-phenyl-4-methyl-thiazol-2-yl-amin-derivate als inhibitoren von phosphatidylinositol-3-kinase- enzymen (pi3) zur behandlung entzündlicher erkrankungen der luftwege
DE60303238D1 (de) Pyrimidin-Essigsäure Derivate geeignet zur Behandlung von CRTH2-bedingten Krankheiten
DE602005007717D1 (de) Imidazolverbindungen zur behandlung von neurodegenerativen erkrankungen
ATE387194T1 (de) Verwendung eines ibat-hemmers zur behandlung oder vorbeugung von verstopfung
EP1827493A4 (en) USE OF ANTI-ABETA ANTIBODIES FOR THE TREATMENT OF BRAIN TRAUMA
DE602005007499D1 (de) Herstellung von 3-hydroxycarbonsäure unter verwendung von nitrilasemutanten
DE602005001929D1 (de) Sulfonamidderivate zur behandlung von krankheiten
DE602005013819D1 (de) Pyridincarbonsäureamidderivate zur verwendung als antikrebsmittel
EP1812427A4 (en) FATTY ACID AMIDE HYDROLASE OXADIAZOLE KETONE INHIBITORS
ATE517085T1 (de) Zur behandlung von atemwegserkrankungen geeignete phenoxyessigsäurederivate
DE602005002930D1 (de) Sulfonamidderivate zur behandlung von krankheiten
ATE542536T1 (de) 3-ä4-(dibenzoäb,füä1,4üoxazepin-11-yl)-piperazi - 1-ylü-2,2-dimethyl propansäure zur verwendung in der behandlung von schlafstörungen
ATE509621T1 (de) Verwendung von 2,5-dihydroxybenzolderivaten zur behandlung von arthritis und schmerzen
DE602004022035D1 (de) Verwendung von pthalide derivativen zur behandlung
DE602005012481D1 (de) 2,7-substituierte 5-amino-4-hydroxy-8-(1h-indol-5-yl)-octanamid derivate als renin inhibitoren zur behandlung von bluthochdruck
ATE518867T1 (de) Benzothienoä2,3-düpyrimidin-verindungen als inhibitoren der aktivität der tyrosinkinase epidermaler wachstumsfaktorrezeptoren zur behandlung hyperproliferativer krankheiten
EP1651237A4 (en) METHODS OF TREATING DERMATOLOGICAL DISORDERS
DE60309719D1 (de) N-substituierte-1h-indol-5-propansäure verbindungen als ppar-agonisten zur behandlung von diabetis
ATE401878T1 (de) Verwendung von phenoxyessigsäurederivaten zur behandlung der hyperaktiven blase
ATE439347T1 (de) 7-(2h-pyrazol-3-yl)-3,5-dihydroxy-heptansäure- derivate als hmg-co-a-reductase-inhibitoren zur behandlung von lipidemia
ATE483460T1 (de) Amino-oxo-indolyliden-verbindungen zur verwendung in der behandlung von juckender kopfhaut
EP4166138C0 (en) USE OF BROMOPHENOL-PYRAZOLINE COMPOUNDS FOR THE TREATMENT OF CORONAVIRUS DISEASES OF FELINES
DE602006007323D1 (de) VERWENDUNG VON BAFF ZUR BEHANDLUNG Th2-INDUZIERTER LEIDEN

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1620085

Country of ref document: EP